Literature DB >> 9445233

Long-term results of hepaticojejunostomy for benign lesions of the bile ducts.

M A Röthlin1, M Löpfe, R Schlumpf, F Largiadèr.   

Abstract

BACKGROUND: Hepaticojejunostomy has been the method of choice for the treatment of benign lesions of the extrahepatic bile ducts for years. In the era of minimally invasive and interventional techniques, a review of its long-term results is necessary to set the standard with which these new techniques have to be compared.
METHODS: A retrospective analysis was carried out for 51 patients (16 females, 35 males) aged 24 to 83 years (average 48 +/- 13) who had undergone hepaticojejunostomy for benign lesions at our institution between 1980 and 1989. Twelve patients had had up to 4 prior operations of their bile ducts. The main indications for operation were chronic pancreatitis (n = 33) and iatrogenic bile duct lesions (n = 15). If possible, a low end-to-side hepaticojejunostomy was performed. The Hepp-Couinaud approach was saved for high strictures and recurrences. All patients were reassessed by questionnaire at an average of 7.6 years (range 2 to 13) after the operation.
RESULTS: Four Hepp-Couinaud and 47 low hepaticojejunostomies were performed. Postoperative complications were seen in 17 patients (33%), 4 of whom had a reoperation. One patient died, for a mortality rate of 2%. The hospital stay averaged 24 +/- 17 days (range 8 to 90). Late complications developed in 13 patients (25%) 2 months to 6 years after the operation. Stenosis and cholangitis necessitated reoperation in 3 cases, cholangitis without stenosis was treated in 4, and other complications were seen in 5 cases. One patient died with a liver abscess, and 12 died of causes unrelated to the operation. When questioned, 31 of 35 patients were in good or very good condition.
CONCLUSIONS: Hepaticojejunostomy is a safe and reliable method for the treatment of benign lesions of the bile ducts even in young patients in need of a long-term biliary bypass.

Entities:  

Mesh:

Year:  1998        PMID: 9445233     DOI: 10.1016/s0002-9610(97)00229-8

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  30 in total

1.  Incidence of hepaticojejunostomy stricture after hepaticojejunostomy.

Authors:  Francesca M Dimou; Deepak Adhikari; Hemalkumar B Mehta; Kelly Olino; Taylor S Riall; Kimberly M Brown
Journal:  Surgery       Date:  2016-07-06       Impact factor: 3.982

2.  Major bile duct injury requiring operative reconstruction after laparoscopic cholecystectomy: a follow-on study.

Authors:  Patrick J Worth; Taranjeet Kaur; Brian S Diggs; Brett C Sheppard; John G Hunter; James P Dolan
Journal:  Surg Endosc       Date:  2015-08-15       Impact factor: 4.584

Review 3.  Current management of biliary strictures.

Authors:  Jennifer G Hall; Theodore N Pappas
Journal:  J Gastrointest Surg       Date:  2004-12       Impact factor: 3.452

4.  A gallbladder conduit for bile duct reconstruction to treat benign biliary stenosis.

Authors:  Gregory Kouraklis
Journal:  Surg Today       Date:  2006       Impact factor: 2.549

5.  A novel biodegradable biliary stent in the normal duct hepaticojejunal anastomosis: an 18-month follow-up in a large animal model.

Authors:  Johanna M Laukkarinen; Juhani A Sand; Pierce Chow; Hanne Juuti; Minna Kellomäki; Päivi Kärkkäinen; Jorma Isola; Sidney Yu; Satchithanantham Somanesan; Irene Kee; In Chin Song; Teck Hin Ng; Isto H Nordback
Journal:  J Gastrointest Surg       Date:  2007-06       Impact factor: 3.452

6.  Gallstone in jejunal limb with jejunocolonic fistula 10 years after Roux-en-Y choledochojejunostomy.

Authors:  Tao Suo; Lu-Jun Song; Sai-Xiong Tong
Journal:  World J Radiol       Date:  2011-01-28

7.  Clinical trial report: endoscopic treatment of postoperative bile duct strictures using multiple stents: long-term results.

Authors:  John Baillie
Journal:  Curr Gastroenterol Rep       Date:  2011-04

8.  Portoenterostomy as a Salvage Procedure for Major Biliary Complications Following Hepaticojejunostomy.

Authors:  Amit Sharma; John S Hammond; Emmanouil Psaltis; W Keith Dunn; Dileep N Lobo
Journal:  J Gastrointest Surg       Date:  2017-02-08       Impact factor: 3.452

9.  Repair of bile duct defect with degradable stent and autologous tissue in a porcine model.

Authors:  Yue-Long Liang; Yi-Chen Yu; Kun Liu; Wei-Jia Wang; Jiang-Bo Ying; Yi-Fan Wang; Xiu-Jun Cai
Journal:  World J Gastroenterol       Date:  2012-10-07       Impact factor: 5.742

10.  Percutaneous transhepatic cholangioscopic intervention in the management of complete membranous occlusion of bilioenteric anastomosis: report of two cases.

Authors:  Dong-Hoon Yang; Sung Koo Lee; Sung-Hoon Moon; Do Hyun Park; Sang Soo Lee; Dong Wan Seo; Myung-Hwan Kim
Journal:  Gut Liver       Date:  2009-12-31       Impact factor: 4.519

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.